FOGLI, STEFANO Statistiche
FOGLI, STEFANO
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review
2024-01-01 Martorana, F.; Sano, M. V.; Valerio, M. R.; Fogli, S.; Vigneri, P.; Danesi, R.; Gebbia, V.
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
2024-01-01 Del Re, Marzia; Luculli, Giovanna Irene; Petrini, Iacopo; Sbrana, Andrea; Scotti, Vieri; Perez, Diego de Miguel; Livi, Lorenzo; Crucitta, Stefania; Iannopollo, Mauro; Mazzoni, Francesca; Ruglioni, Martina; Tibaldi, Carmelo; Olmetto, Emanuela; Stasi, Irene; Baldini, Editta; Allegrini, Giacomo; Antonuzzo, Lorenzo; Morelli, Franco; Pierini, Andrea; Panzeri, Nicola; Fogli, Stefano; Chella, Antonio; Rolfo, Christian; Danesi, Romano
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
2024-01-01 Zatelli, M. C.; Faggiano, A.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Franchina, T.; Giorgino, F.; Marrano, N.; Giuffrida, D.; Gori, S.; Marino, G.; Mazzilli, R.; Monami, M.; Montagnani, M.; Morviducci, L.; Natalicchio, A.; Ragni, A.; Renzelli, V.; Russo, A.; Sciacca, L.; Tuveri, E.; Aimaretti, G.; Avogaro, A.; Candido, R.; Di Maio, M.; Silvestris, N.; Gallo, M.
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
2024-01-01 Natalicchio, A; Marrano, N; Montagnani, M; Gallo, M; Faggiano, A; Zatelli, M C; Argentiero, A; Del Re, M; D'Oronzo, S; Fogli, S; Franchina, T; Giuffrida, D; Gori, S; Ragni, A; Marino, G; Mazzilli, R; Monami, M; Morviducci, L; Renzelli, V; Russo, A; Sciacca, L; Tuveri, E; Cortellini, A; Di Maio, M; Candido, R; Perrone, F; Aimaretti, G; Avogaro, A; Silvestris, N; Giorgino, F
Opioid metabolism and drug-drug interaction in cancer
2024-01-01 Aapro, Matti; Fogli, Stefano; Morlion, Bart; Danesi, Romano
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer
2024-01-01 Guglielmi, Giorgio; Del Re, Marzia; Gol, Leila Sadeghi; Bengala, Carmelo; Danesi, Romano; Fogli, Stefano
Targeting HER2 in breast cancer with brain metastases: A pharmacological point of view with special focus on the permeability of blood-brain barrier to targeted treatments
2024-01-01 Guglielmi, Giorgio; Zamagni, Claudio; DEL RE, Marzia; Danesi, Romano; Fogli, Stefano
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma
2024-01-01 Crucitta, Stefania; Cucchiara, Federico; Marconcini, Riccardo; Bulleri, Alessandra; Manacorda, Simona; Capuano, Annalisa; Cioni, Dania; Nuzzo, Amedeo; de Jonge, Evert; Mathjissen, Ron H J; Neri, Emanuele; van Schaik, Ron H N; Fogli, Stefano; Danesi, Romano; Del Re, Marzia
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
2023-01-01 Crucitta, Stefania; Ruglioni, Martina; Novi, Claudia; Manganiello, Mascia; Arici, Roberta; Petrini, Iacopo; Pardini, Eleonora; Cucchiara, Federico; Marmorino, Federica; Cremolini, Chiara; Fogli, Stefano; Danesi, Romano; Del Re, Marzia
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics
2023-01-01 Guglielmi, Giorgio; Crucitta, Stefania; Bertani, Lorenzo; Ruglioni, Martina; Svizzero, Giovanni Baiano; Ceccarelli, Linda; Del Re, Marzia; Danesi, Romano; Costa, Francesco; Fogli, Stefano
Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data
2023-01-01 Giordano, Guido; Griguolo, Gaia; Landriscina, Matteo; Meattini, Icro; Carbone, Francesco; Leone, Augusto; Del Re, Marzia; Fogli, Stefano; Danesi, Romano; Colamaria, Antonio; Dieci, Maria Vittoria
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib
2022-01-01 Del Re, Marzia; Crucitta, Stefania; Omarini, Claudia; Bargagna, Irene; Mongillo, Marta; Palleschi, Michela; Stucci, Stefania; Meattini, Icro; D'Onofrio, Raffaella; Lorenzini, Giulia; Biondani, Pamela; De Giorgi, Ugo; Porta, Camillo; Livi, Lorenzo; Natalizio, Salvatore; Fontana, Andrea; Giontella, Elena; Angelini, Lucia; Fogli, Stefano; Danesi, Romano
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
2022-01-01 Faggiano, A.; Mazzilli, R.; Natalicchio, A.; Adinolfi, V.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Gallo, M.; Giuffrida, D.; Gori, S.; Montagnani, M.; Ragni, A.; Renzelli, V.; Russo, A.; Silvestris, N.; Franchina, T.; Tuveri, E.; Cinieri, S.; Colao, A.; Giorgino, F.; Zatelli, M. C.
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
2022-01-01 Del Re, M.; Omarini, C.; Diodati, L.; Palleschi, M.; Meattini, I.; Crucitta, S.; Lorenzini, G.; Isca, C.; Fontana, A.; Livi, L.; Piacentini, F.; Fogli, S.; De Giorgi, U.; Danesi, R.
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences
2022-01-01 Fogli, Stefano; Tabbò, Fabrizio; Capuano, Annalisa; DEL RE, Marzia; Passiglia, Francesco; Cucchiara, Federico; Scavone, Cristina; Gori, Veronica; Novello, Silvia; Schmidinger, Manuela; Danesi, Romano
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors
2021-01-01 Del Re, M.; van Schaik, R. H. N.; Fogli, S.; Mathijssen, R. H. J.; Cucchiara, F.; Capuano, A.; Scavone, C.; Jenster, G. W.; Danesi, R.
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer
2021-01-01 Fogli, S.; Gianfilippo, G.; Cucchiara, F.; Del Re, M.; Valerio, L.; Elisei, R.; Danesi, R.
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management
2021-01-01 Cucchiara, Federico; Scarpitta, Rosa; Crucitta, Stefania; Scatena, Cristian; Arici, Roberta; Naccarato, Antonio Giuseppe; Fogli, Stefano; Danesi, Romano; Del Re, Marzia
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
2021-01-01 Del Re, M.; Omarini, C.; Diodati, L.; Palleschi, M.; Meattini, I.; Crucitta, S.; Lorenzini, G.; Isca, C.; Fontana, A.; Livi, L.; Piacentini, F.; Fogli, S.; De Giorgi, U.; Danesi, R.
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards
2021-01-01 Danesi, R; Fogli, S; Indraccolo, S; Del Re, M; Dei Tos, A P; Leoncini, L; Antonuzzo, L; Bonanno, L; Guarneri, V; Pierini, A; Amunni, G; Conte, P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review | 1-gen-2024 | Martorana, F.; Sano, M. V.; Valerio, M. R.; Fogli, S.; Vigneri, P.; Danesi, R.; Gebbia, V. | |
| Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression | 1-gen-2024 | Del Re, Marzia; Luculli, Giovanna Irene; Petrini, Iacopo; Sbrana, Andrea; Scotti, Vieri; Perez, Diego de Miguel; Livi, Lorenzo; Crucitta, Stefania; Iannopollo, Mauro; Mazzoni, Francesca; Ruglioni, Martina; Tibaldi, Carmelo; Olmetto, Emanuela; Stasi, Irene; Baldini, Editta; Allegrini, Giacomo; Antonuzzo, Lorenzo; Morelli, Franco; Pierini, Andrea; Panzeri, Nicola; Fogli, Stefano; Chella, Antonio; Rolfo, Christian; Danesi, Romano | |
| Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group | 1-gen-2024 | Zatelli, M. C.; Faggiano, A.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Franchina, T.; Giorgino, F.; Marrano, N.; Giuffrida, D.; Gori, S.; Marino, G.; Mazzilli, R.; Monami, M.; Montagnani, M.; Morviducci, L.; Natalicchio, A.; Ragni, A.; Renzelli, V.; Russo, A.; Sciacca, L.; Tuveri, E.; Aimaretti, G.; Avogaro, A.; Candido, R.; Di Maio, M.; Silvestris, N.; Gallo, M. | |
| Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view | 1-gen-2024 | Natalicchio, A; Marrano, N; Montagnani, M; Gallo, M; Faggiano, A; Zatelli, M C; Argentiero, A; Del Re, M; D'Oronzo, S; Fogli, S; Franchina, T; Giuffrida, D; Gori, S; Ragni, A; Marino, G; Mazzilli, R; Monami, M; Morviducci, L; Renzelli, V; Russo, A; Sciacca, L; Tuveri, E; Cortellini, A; Di Maio, M; Candido, R; Perrone, F; Aimaretti, G; Avogaro, A; Silvestris, N; Giorgino, F | |
| Opioid metabolism and drug-drug interaction in cancer | 1-gen-2024 | Aapro, Matti; Fogli, Stefano; Morlion, Bart; Danesi, Romano | |
| Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer | 1-gen-2024 | Guglielmi, Giorgio; Del Re, Marzia; Gol, Leila Sadeghi; Bengala, Carmelo; Danesi, Romano; Fogli, Stefano | |
| Targeting HER2 in breast cancer with brain metastases: A pharmacological point of view with special focus on the permeability of blood-brain barrier to targeted treatments | 1-gen-2024 | Guglielmi, Giorgio; Zamagni, Claudio; DEL RE, Marzia; Danesi, Romano; Fogli, Stefano | |
| TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma | 1-gen-2024 | Crucitta, Stefania; Cucchiara, Federico; Marconcini, Riccardo; Bulleri, Alessandra; Manacorda, Simona; Capuano, Annalisa; Cioni, Dania; Nuzzo, Amedeo; de Jonge, Evert; Mathjissen, Ron H J; Neri, Emanuele; van Schaik, Ron H N; Fogli, Stefano; Danesi, Romano; Del Re, Marzia | |
| Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer | 1-gen-2023 | Crucitta, Stefania; Ruglioni, Martina; Novi, Claudia; Manganiello, Mascia; Arici, Roberta; Petrini, Iacopo; Pardini, Eleonora; Cucchiara, Federico; Marmorino, Federica; Cremolini, Chiara; Fogli, Stefano; Danesi, Romano; Del Re, Marzia | |
| Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics | 1-gen-2023 | Guglielmi, Giorgio; Crucitta, Stefania; Bertani, Lorenzo; Ruglioni, Martina; Svizzero, Giovanni Baiano; Ceccarelli, Linda; Del Re, Marzia; Danesi, Romano; Costa, Francesco; Fogli, Stefano | |
| Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data | 1-gen-2023 | Giordano, Guido; Griguolo, Gaia; Landriscina, Matteo; Meattini, Icro; Carbone, Francesco; Leone, Augusto; Del Re, Marzia; Fogli, Stefano; Danesi, Romano; Colamaria, Antonio; Dieci, Maria Vittoria | |
| Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib | 1-gen-2022 | Del Re, Marzia; Crucitta, Stefania; Omarini, Claudia; Bargagna, Irene; Mongillo, Marta; Palleschi, Michela; Stucci, Stefania; Meattini, Icro; D'Onofrio, Raffaella; Lorenzini, Giulia; Biondani, Pamela; De Giorgi, Ugo; Porta, Camillo; Livi, Lorenzo; Natalizio, Salvatore; Fontana, Andrea; Giontella, Elena; Angelini, Lucia; Fogli, Stefano; Danesi, Romano | |
| Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper | 1-gen-2022 | Faggiano, A.; Mazzilli, R.; Natalicchio, A.; Adinolfi, V.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Gallo, M.; Giuffrida, D.; Gori, S.; Montagnani, M.; Ragni, A.; Renzelli, V.; Russo, A.; Silvestris, N.; Franchina, T.; Tuveri, E.; Cinieri, S.; Colao, A.; Giorgino, F.; Zatelli, M. C. | |
| Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients | 1-gen-2022 | Del Re, M.; Omarini, C.; Diodati, L.; Palleschi, M.; Meattini, I.; Crucitta, S.; Lorenzini, G.; Isca, C.; Fontana, A.; Livi, L.; Piacentini, F.; Fogli, S.; De Giorgi, U.; Danesi, R. | |
| The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences | 1-gen-2022 | Fogli, Stefano; Tabbò, Fabrizio; Capuano, Annalisa; DEL RE, Marzia; Passiglia, Francesco; Cucchiara, Federico; Scavone, Cristina; Gori, Veronica; Novello, Silvia; Schmidinger, Manuela; Danesi, Romano | |
| Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors | 1-gen-2021 | Del Re, M.; van Schaik, R. H. N.; Fogli, S.; Mathijssen, R. H. J.; Cucchiara, F.; Capuano, A.; Scavone, C.; Jenster, G. W.; Danesi, R. | |
| Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer | 1-gen-2021 | Fogli, S.; Gianfilippo, G.; Cucchiara, F.; Del Re, M.; Valerio, L.; Elisei, R.; Danesi, R. | |
| Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management | 1-gen-2021 | Cucchiara, Federico; Scarpitta, Rosa; Crucitta, Stefania; Scatena, Cristian; Arici, Roberta; Naccarato, Antonio Giuseppe; Fogli, Stefano; Danesi, Romano; Del Re, Marzia | |
| Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients | 1-gen-2021 | Del Re, M.; Omarini, C.; Diodati, L.; Palleschi, M.; Meattini, I.; Crucitta, S.; Lorenzini, G.; Isca, C.; Fontana, A.; Livi, L.; Piacentini, F.; Fogli, S.; De Giorgi, U.; Danesi, R. | |
| Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards | 1-gen-2021 | Danesi, R; Fogli, S; Indraccolo, S; Del Re, M; Dei Tos, A P; Leoncini, L; Antonuzzo, L; Bonanno, L; Guarneri, V; Pierini, A; Amunni, G; Conte, P |